- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01015183
Prevention Chemotherapy Induced Mucositis by Zinc Sulfate
July 25, 2011 updated by: Tehran University of Medical Sciences
Prevention High Dose Chemotherapy Induced Mucositis by Using Zinc Sulfate
In this double blinded randomized study we evaluate effect of Zinc sulfate for prevention mucositis due to high dose chemotherapy in the patients undergoing bone marrow transplantation whose received Busulfan and/or Cyclophosphamide.
Patients randomized in two groups: intervention and control with balanced block randomization method.
Intervention group received Zinc sulfate immediately after start conditioning regimen and continued for two weeks.
Control group received placebo at the same manner.
Prevalence and severity of mucositis will be compared in two groups.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Tehran, Iran, Islamic Republic of, 14114
- Hematology-Oncology & SCT Research Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient undergoing bone marrow transplantation
- Signed informed consent
Exclusion Criteria:
- Unable take drug (or placebo) orally
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Received Zinc Sulfate
|
Zinc Sulfate: 100 mg of zinc element, per day, bid for two weeks start with chemotherapy
|
Placebo Comparator: Control
Control group
|
Placebo: as the same of intervention group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The effect of Zinc Sulfate on prevention of mucositis in patients undergoing bone marrow transplantation
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Evaluation of Zinc Sulfate concentration
Time Frame: 1 year
|
1 year
|
Evaluation of Zinc Sulfate advance effects
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Molouk Hadjibabaie, PhD, Hematology-Oncology and SCT Research Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2009
Primary Completion (Actual)
November 1, 2010
Study Completion (Actual)
June 1, 2011
Study Registration Dates
First Submitted
November 17, 2009
First Submitted That Met QC Criteria
November 17, 2009
First Posted (Estimate)
November 18, 2009
Study Record Updates
Last Update Posted (Estimate)
July 26, 2011
Last Update Submitted That Met QC Criteria
July 25, 2011
Last Verified
July 1, 2011
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HORCSCT-0904
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mucositis
-
Salma Hesham ElhoufiRecruitingOral Mucositis (Ulcerative) Due to Radiation | Radiation-Induced Mucositis | Radiation MucositisEgypt
-
Galera Therapeutics, Inc.CompletedRadiation Induced Oral MucositisUnited States, Canada, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI)WithdrawnMalignant Neoplasm | Gastrointestinal Mucositis
-
Hadassah Medical OrganizationCompletedChemotherapy Induced MucositisIsrael
-
Air Force Military Medical University, ChinaNot yet recruitingMucositis OralChina
-
University Hospital, ToulouseRecruiting
-
Catalysis SLCompletedMucositis OralRussian Federation
-
Ghada zakiNot yet recruiting
-
Federico II UniversityRecruitingPeri-implant Mucositis | Mucositis OralItaly
-
Tata Memorial CentreRecruitingOral Mucositis (Ulcerative)India
Clinical Trials on Zinc Sulfate
-
International Centre for Diarrhoeal Disease Research...Completed
-
Instituto Nacional de Salud Publica, MexicoUNICEFCompletedDiarrhea, Infantile | Diarrhoea;AcuteMexico
-
Hormozgan University of Medical SciencesCompleted
-
University of VermontNational Heart, Lung, and Blood Institute (NHLBI)Active, not recruiting
-
Babylon UniversityMinistry of Health, IraqCompletedAsthenozoospermiaIraq
-
mahmoud hussein hadwanMinistry of Health, IraqCompleted
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedGastric Carcinoma | Unresectable Pancreatic Carcinoma | Liver and Intrahepatic Bile Duct Carcinoma | Unresectable Esophageal CarcinomaUnited States
-
Universidad Nacional Autonoma de MexicoHospital General de Mexico; Hospital Pediatrico de CoyoacanCompletedPneumonia | Children, OnlyMexico
-
Mansoura UniversityCompleted
-
UCSF Benioff Children's Hospital OaklandChildren's Hospital Medical Center, CincinnatiCompletedCritical IllnessUnited States